41.31
1.64%
-0.69
Finanzdaten der Apellis Pharmaceuticals Inc-Aktie (APLS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
32.59%
146.38
|
110.40 | 94.97 | 44.85 | 22.66 |
Operating Expenses
|
6.70%
230.90
|
247.48 | 215.41 | 219.93 | 186.72 |
Benefits Costs and Expenses |
6.74%
233.53
|
250.40 | 216.81 | 222.34 | 190.12 |
Costs And Expenses |
6.74%
233.53
|
250.40 | 216.81 | 222.34 | 190.12 |
Operating Income/Loss |
38.34%
-84.52
|
-137.08 | -120.44 | -175.08 | -164.05 |
Income/Loss From Continuing Operations Before Tax |
37.75%
-87.15
|
-140.00 | -121.84 | -177.50 | -167.46 |
Income Tax Expense/Benefit |
510.73%
1.423
|
0.233 | 0.194 | 0.282 | -1.471 |
Income/Loss From Continuing Operations After Tax |
36.84%
-88.58
|
-140.24 | -122.04 | -177.78 | -165.99 |
Net Income/Loss
|
36.84%
-88.58
|
-140.24 | -122.04 | -177.78 | -165.99 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
98,460%
118.56
|
0.1203 | 0.1193 | 0.1139 | 106.01 |
Diluted Average Shares |
98,460%
118.56
|
0.1203 | 0.1193 | 0.1139 | 106.01 |
Basic Earnings Per Share |
38.46%
-0.72
|
-1.17 | -1.02 | -1.56 | -1.50 |
Diluted Earnings Per Share |
38.46%
-0.72
|
-1.17 | -1.02 | -1.56 | -1.50 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Kapitalisierung:
|
Volumen (24h):